NovoCure Ltd (NASDAQ: NVCR) kicked off on Friday, up 5.26% from the previous trading day, before settling in for the closing price of $17.1. Over the past 52 weeks, NVCR has traded in a range of $14.17-$34.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -83.87% over the last five years. While this was happening, its average annual earnings per share was recorded -4.67%. With a float of $98.79 million, this company’s outstanding shares have now reached $111.48 million.
The firm has a total of 1488 workers. Let’s measure their productivity. In terms of profitability, gross margin is 77.16%, operating margin of -26.84%, and the pretax margin is -20.88%.
NovoCure Ltd (NVCR) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of NovoCure Ltd is 11.39%, while institutional ownership is 85.15%. The most recent insider transaction that took place on Jun 03 ’25, was worth 17,259. In this transaction Director of this company sold 999 shares at a rate of $17.28, taking the stock ownership to the 3,054 shares. Before that another transaction happened on Jun 03 ’25, when Company’s Director sold 999 for $17.31, making the entire transaction worth $17,297. This insider now owns 81,229 shares in total.
NovoCure Ltd (NVCR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.60% during the next five years compared to -83.87% drop over the previous five years of trading.
NovoCure Ltd (NASDAQ: NVCR) Trading Performance Indicators
Take a look at NovoCure Ltd’s (NVCR) current performance indicators. Last quarter, stock had a quick ratio of 1.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of NovoCure Ltd (NVCR)
Analysing the last 5-days average volume posted by the [NovoCure Ltd, NVCR], we can find that recorded value of 1.81 million was better than the volume posted last year of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 66.87%.
During the past 100 days, NovoCure Ltd’s (NVCR) raw stochastic average was set at 32.16%, which indicates a significant decrease from 59.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.81% in the past 14 days, which was lower than the 59.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.58, while its 200-day Moving Average is $20.17. Now, the first resistance to watch is $18.35. This is followed by the second major resistance level at $18.71. The third major resistance level sits at $19.37. If the price goes on to break the first support level at $17.33, it is likely to go to the next support level at $16.67. Should the price break the second support level, the third support level stands at $16.31.
NovoCure Ltd (NASDAQ: NVCR) Key Stats
The company with the Market Capitalisation of 2.01 billion has total of 111,486K Shares Outstanding. Its annual sales at the moment are 605,220 K in contrast with the sum of -168,630 K annual income. Company’s last quarter sales were recorded 154,990 K and last quarter income was -34,320 K.
